HeadSpace, GC
IndustriesPharma & Biopharma
ManufacturerShimadzu
Importance of the Topic
Residual solvents in pharmaceutical active ingredients pose health risks and impact product quality. Regulatory guidelines require precise quantification to ensure patient safety and manufacturing compliance.
Objectives and Study Overview
This study aimed to establish a high throughput headspace GC method to analyze a broad range of residual solvents in Valsartan API. The focus was on reducing run time, minimizing carryover, and validating method performance in line with international guidelines.
Methodology
40 target solvents were prepared in N-Methyl-2-Pyrrolidone and subjected to headspace sampling. Calibration standards covered five levels from limit of quantification to 150 of specification limits. Sample and spike preparations were performed at LOQ and working levels. Method validation included linearity, precision, accuracy, LOQ determination and critical resolution assessment.
Instrumentation
- Nexis GC-2030 gas chromatograph equipped with flame ionization detector
- HS-20 NX headspace autosampler employing short transfer line and continuous isolation gas flow
- SH-Rxi-624 capillary column (20 m length, 0.18 mm ID, 1 µm film thickness)
Main Results and Discussion
Calibration curves for all solvents exhibited correlation coefficients above 0.99. Limits of quantification met sensitivity requirements with RSD below 15 for LOQ and working levels. Overlapping vial function reduced analysis time by one third when processing multiple samples sequentially. Short transfer line and isolation gas flow effectively minimized carryover, even for high boiling compounds. Critical solvent pairs with resolution below 1.5 were identified and can be further optimized.
Benefits and Practical Applications
- Simultaneous analysis of multiple solvent classes in a single run
- Improved laboratory throughput and productivity
- Reduced solvent and utility consumption
- Compliance with ICH Q3C guidelines for residual solvents
Future Trends and Possibilities of Use
Further integration of automated sample handling and advanced data processing could enhance throughput. Emerging detector technologies and green solvent approaches may expand the method to new matrices. Artificial intelligence in chromatographic optimization and real-time monitoring are promising developments.
Conclusion
The developed high throughput HS-GC-FID method on the Nexis GC-2030 with HS-20 NX autosampler meets validation criteria and offers a robust solution for comprehensive residual solvent analysis in pharmaceutical APIs.
References
- ICH Q2(R2) Validation of Analytical Procedures
- ICH Q3C(R9) Guidelines for Residual Solvents
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.